Table 1.
Characteristics of the study population according to the main clinical course during the observation period.
N | All (n = 1024) | Clinical course |
p-value | ||
---|---|---|---|---|---|
Positive (n = 637) | Fluctuating (n = 66) | Negative (n = 321) | |||
Age (years) | 78.07 (9.32) | 77.25 (9.36) | 72.29 (8.55) | 80.88 (8.51) | <0.001 |
Women | 513 (50.1) | 342 (53.7) | 28 (42.4) | 143 (44.5) | 0.012 |
Living arrangementa | <0.001 | ||||
At home, alone | 521 (50.9) | 355 (55.7) | 52 (78.8) | 114 (35.5) | |
At home, assisted | 196 (19.1) | 113 (17.7) | 3 (4.5) | 80 (24.9) | |
Institutionalized | 189 (18.5) | 111 (17.4) | 3 (4.5) | 75 (23.4) | |
Low mobility levela | 373 (36.4) | 206 (32.3) | 4 (6.1) | 163 (50.8) | <0.001 |
Smoking habitsa | 0.027 | ||||
Never | 367 (35.8) | 222 (34.9) | 31 (47.0) | 114 (35.5) | |
Former | 149 (14.6) | 83 (13.0) | 14 (21.2) | 52 (16.2) | |
Current | 26 (2.5) | 14 (2.2) | 3 (4.5) | 9 (2.8) | |
Covid-19 wave II | 126 (12.3) | 76 (11.9) | 16 (24.2) | 34 (10.6) | 0.008 |
N. chronic diseases | 4.06 (2.66) | 3.88 (2.65) | 3.50 (2.38) | 4.53 (2.67) | <0.001 |
Diabetes mellitus | 258 (25.2) | 163 (25.6) | 17 (25.8) | 78 (24.3) | 0.905 |
Chronic liver diseases | 24 (2.3) | 14 (2.2) | 3 (4.5) | 7 (2.2) | 0.474 |
Osteoporosis | 277 (27.1) | 181 (28.4) | 8 (12.1) | 88 (27.4) | 0.018 |
Osteoarthrosis | 219 (21.4) | 141 (22.1) | 7 (10.6) | 71 (22.1) | 0.087 |
Hypertension | 694 (67.8) | 425 (66.7) | 45 (68.2) | 224 (69.8) | 0.631 |
CVD | 590 (57.6) | 338 (53.1) | 42 (63.6) | 210 (65.4) | 0.001 |
Cerebrovascular diseases | 111 (10.8) | 59 (9.3) | 4 (6.1) | 48 (15.0) | 0.012 |
Chronic respiratory diseases | 146 (14.3) | 87 (13.7) | 8 (12.1) | 51 (15.9) | 0.568 |
CKD | 135 (13.2) | 79 (12.4) | 3 (4.5) | 53 (16.5) | 0.021 |
Depressive disorders | 181 (17.7) | 114 (17.9) | 11 (16.7) | 56 (17.4) | 0.961 |
Cognitive disorders | 164 (16.0) | 100 (15.7) | 1 (1.5) | 63 (19.6) | 0.001 |
Obesity | 153 (14.9) | 82 (12.9) | 17 (25.8) | 54 (16.8) | 0.01 |
WHO status at ward admission | <0.001 | ||||
Mild disease, no O2 | 303 (29.6) | 232 (36.4) | 23 (34.8) | 48 (15.0) | |
Mild disease, low-flow O2 | 445 (43.5) | 270 (42.4) | 38 (57.6) | 137 (42.7) | |
Severe disease, high-flow O2/NIV | 248 (24.2) | 117 (18.4) | 5 (7.6) | 126 (39.3) | |
Severe disease, organ support | 28 (2.7) | 18 (2.8) | 0 (0.0) | 10 (3.1) |
Abbreviations: CVD, cardiovascular diseases; CKD, chronic kidney disease; WHO, World Health Organization.
Missing values in living arrangements (n = 118), mobility level (n = 31), smoking habits (n = 482). P-values refer to the comparison between different categories of clinical trajectory.